These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 558623)
1. Influence of fasting on the absorption and effects of delta9-tetrahydrocannabinol after oral administration in sesame oil. Pryor GT; Husain S; Mitoma C Pharmacol Biochem Behav; 1977 Mar; 6(3):331-41. PubMed ID: 558623 [TBL] [Abstract][Full Text] [Related]
2. Factors influencing tolerance to the effects of delta9-THC on a conditioned avoidance response. Larsen FF; Pryor GT Pharmacol Biochem Behav; 1977 Oct; 7(4):323-9. PubMed ID: 928490 [TBL] [Abstract][Full Text] [Related]
3. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats. Pryor GT; Larsen FF; Husain S; Braude MC Pharmacol Biochem Behav; 1978 Mar; 8(3):295-318. PubMed ID: 652837 [TBL] [Abstract][Full Text] [Related]
4. Interactions between delta9-tetrahydrocannabinol and phencyclidine hydrochloride in rats. Pryor GT; Husain S; Larsen F; McKenzie CE; Carr JD; Braude MC Pharmacol Biochem Behav; 1977 Jan; 6(1):123-36. PubMed ID: 850686 [TBL] [Abstract][Full Text] [Related]
5. Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin. Martin BR; Montgomery J; Dewey WL; Harris LS Drug Metab Dispos; 1978; 6(3):282-7. PubMed ID: 26549 [TBL] [Abstract][Full Text] [Related]
6. Hyperphagia in pre-fed rats following oral delta9-THC. Williams CM; Rogers PJ; Kirkham TC Physiol Behav; 1998 Nov; 65(2):343-6. PubMed ID: 9855485 [TBL] [Abstract][Full Text] [Related]
7. Cross-tolerance between delta9-tetrahydrocannabinol and ethanol: the role of drug disposition. Siemens AJ; Doyle OL Pharmacol Biochem Behav; 1979 Jan; 10(1):49-55. PubMed ID: 441094 [TBL] [Abstract][Full Text] [Related]
9. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC. Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257 [TBL] [Abstract][Full Text] [Related]
10. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Vela G; Martín S; García-Gil L; Crespo JA; Ruiz-Gayo M; Fernández-Ruiz JJ; García-Lecumberri C; Pélaprat D; Fuentes JA; Ramos JA; Ambrosio E Brain Res; 1998 Oct; 807(1-2):101-9. PubMed ID: 9757010 [TBL] [Abstract][Full Text] [Related]
11. Tolerance to the effects of delta9-THC on shuttle-box performance and body temperature. ten Ham M Pharmacol Biochem Behav; 1977 Feb; 6(2):183-5. PubMed ID: 859896 [TBL] [Abstract][Full Text] [Related]
13. Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats. Corchero J; García-Gil L; Manzanares J; Fernández-Ruiz JJ; Fuentes JA; Ramos JA Life Sci; 1998; 63(10):843-50. PubMed ID: 9734704 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC. Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557 [TBL] [Abstract][Full Text] [Related]
15. Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC). Mayer TA; Matar MA; Kaplan Z; Zohar J; Cohen H Pharmacol Biochem Behav; 2014 Jul; 122():307-18. PubMed ID: 24814135 [TBL] [Abstract][Full Text] [Related]
16. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167 [TBL] [Abstract][Full Text] [Related]
17. Effect of delta9-tetrahydrocannabinol on the gastrointestinal tract of the rat. Sofia RD; Diamantis W; Edelson J Pharmacology; 1978; 17(2):79-82. PubMed ID: 684079 [TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory, Antioxidative, and Hepatoprotective Effects of Trans Δ9-Tetrahydrocannabinol/Sesame Oil on Adjuvant-Induced Arthritis in Rats. Ismail M; Hasan H; El-Orfali Y; Ismail H; Khawaja G Evid Based Complement Alternat Med; 2018; 2018():9365464. PubMed ID: 30046349 [TBL] [Abstract][Full Text] [Related]
19. Distribution and metabolism in vivo of 14C-tetrahydrocannabinol in the rat. Willinsky MD; Kalant H; Meresz O; Endrenyi L; Woo N Eur J Pharmacol; 1974 Jun; 27(1):106-19. PubMed ID: 4851409 [No Abstract] [Full Text] [Related]
20. Effects of delta9-tetrahydrocannabinol on social behaviour in mice: comparison between two vehicles. Dorr M; Steinberg H Psychopharmacology (Berl); 1976 May; 47(1):87-91. PubMed ID: 986665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]